| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |